SCHEMBL659632

SCHEMBL659632

O=C(C=Cc1ccc(Oc2ccccc2)cc1)c1ccccc1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.73
BCHE P06276 2/20 0.73
NFKB1 P19838 2/20 0.73
NFKB2 Q00653 2/20 0.73
RELA Q04206 2/20 0.73
MAPT P10636 6/20 0.70
LMNA P02545 4/20 0.70
MAOB P27338 3/20 0.70
TNFRSF1A P19438 2/20 0.70
CYP1B1 Q16678 2/20 0.70
PLIN1 O60240 1/20 0.70
ACHE P22303 1/20 0.70
RECQL P46063 1/20 0.70
PLIN5 Q00G26 1/20 0.70
ABHD5 Q8WTS1 1/20 0.70
KMT2A Q03164 4/20 0.68
RAB9A P51151 4/20 0.68
NPC1 O15118 3/20 0.68
HSPD1 P10809 2/20 0.67
HSPE1 P61604 2/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL659631 1.00 CYP3A4 (0.73) CYP3A4BCHENFKB1NFKB2RELA
Chalcone SCHEMBL28350529 0.95 CYP1B1 (0.79) CYP3A4BCHENFKB1NFKB2RELA
SCHEMBL656919 0.93 CYP1B1 (0.73) CYP3A4BCHENFKB1NFKB2RELA
SCHEMBL656920 0.93 CYP1B1 (0.73) CYP3A4BCHENFKB1NFKB2RELA
SCHEMBL25198805 0.92 XDH (0.70) CYP3A4BCHENFKB1NFKB2RELA
SCHEMBL25195496 0.92 XDH (0.70) CYP3A4BCHENFKB1NFKB2RELA
SCHEMBL2996655 0.91 CYP3A4 (0.66) CYP3A4BCHENFKB1NFKB2RELA
SCHEMBL25194675 0.91 MAPT (0.73) CYP3A4BCHENFKB1NFKB2RELA
SCHEMBL2996653 0.91 CYP3A4 (0.66) CYP3A4BCHENFKB1NFKB2RELA
SCHEMBL2664959 0.91 MAPT (0.73) CYP3A4BCHENFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2349999-B1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIV SAARLAND (DE) 2016-01-27 EP disclosed
US-8912186-B2 Allosteric protein kinase modulators UNIVERSITAET DES SAARLANDES (DE) 2014-12-16 US disclosed
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2012-02-23 US disclosed
EP-2349999-A1 ALLOSTERIC PROTEIN KINASE MODULATORS Universität des Saarlandes (DE) 2011-08-03 EP disclosed
WO-2010043711-A1 ALLOSTERIC PROTEIN KINASE MODULATORS UNIVERSITAET DES SAARLANDES (DE) 2010-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046307-A1 ALLOSTERIC PROTEIN KINASE MODULATORS AURKC, AURKA, AURKB CYP3A4 4232/4885BCHE 3330/4885NFKB1 2405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.